Clinical Trial

Synaptic Loss in Multiple System Atrophy

Recruiting
View on ClinicalTrials.gov →
Summary
In this study the investigators would like to investigate the degree of damage of the synapses, an important part of the neurons vital for the communications between neurons, in Multiple System Atrophy (MSA), and pathology related to abnormal accumulation of a protein named tau, in Progressive Supranuclear Palsy (PSP).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-11-09; most recent amendment 2026-02-06.
Trial Details
NCT Number NCT05121012
Lead Sponsor University of Exeter
Conditions Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)
Enrollment 36 participants
Start Date 2021-09-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-10